Once considered impossible, restoring movement after paralysis is becoming a reality thanks to EU-funded researchers who have developed a device that reconnects the brain to the body. By Alison Jones Spinal cord injury (SCI) remains one of the most devastating neurological conditions, severing communication between the brain and the body and leaving millions worldwide with … Read more
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the balance. By Tom Cassauwers Belgian AI company Kantify was doing business as usual until a cancer diagnosis forced the team to rethink their direction. “We built algorithms … Read more
Although powerful treatments exist for rheumatoid arthritis, doctors can’t always predict which drug will work best for each person. An EU-funded initiative aims to change that by optimising and personalising care. By Ali Jones Over the past two decades, a wave of new drug treatments for rheumatoid arthritis (RA) has allowed many people to live … Read more
Living with a brain disorder often means relying on medication that does not work for everyone and, in some cases, surgery. EU-funded researchers are now investigating whether nanotechnology could one day offer a safer, less invasive alternative. By Michaela Nesvarova For decades, treating serious brain disorders has often meant making a difficult trade-off. Symptoms could … Read more
From routine infections to emerging health threats, being prepared matters. Dr Lennie Derde, newly appointed CEO of the Ecraid medical research network, explains how European collaboration and EU support are strengthening clinical research readiness. By Horizon Magazine Staff Being prepared for emerging infectious diseases is not only about responding to emergencies. It also means having … Read more
Across Europe, cancer researchers are collaborating more closely than ever, thanks to the EU-backed canSERV platform, which links scientists with research services and infrastructures to speed up discoveries and improve care for patients. By Helen Massy-Beresford For Dr Pavla Bouchalová, a cancer researcher in the department of biochemistry at Masaryk University in Brno, Czechia, answering … Read more